Login / Signup

Effectiveness and safety of rituximab in special types of rheumatoid arthritis.

Satoshi TakanashiYasushi KondoShuntaro SaitoJun KikuchiHironari HanaokaTsutomu TakeuchiYuko Kaneko
Published in: International journal of rheumatic diseases (2023)
B-cell depletion by rituximab may be a useful treatment option for patients with lymphoproliferative disorder and rheumatoid vasculitis.
Keyphrases
  • rheumatoid arthritis
  • diffuse large b cell lymphoma
  • epstein barr virus
  • hodgkin lymphoma
  • chronic lymphocytic leukemia
  • disease activity
  • replacement therapy